Cargando…

Therapeutic modulation of inflammasome pathways

Inflammasomes are macromolecular complexes formed in response to pathogen‐associated molecular patterns (PAMPs) and danger‐associated molecular patterns (DAMPs) that drive maturation of the pro‐inflammatory cytokines interleukin (IL)‐1β and IL‐18, and cleave gasdermin D (GSDMD) for induction of pyro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chauhan, Dhruv, Vande Walle, Lieselotte, Lamkanfi, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Invited Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497261/ https://www.ncbi.nlm.nih.gov/pubmed/32770571 http://dx.doi.org/10.1111/imr.12908

Ejemplares similares

Inflammasomes: Caspase-1-Activating Platforms with Critical Roles in Host Defense
por: Vande Walle, Lieselotte, et al.
Publicado: (2011)

Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation
por: Van Opdenbosch, Nina, et al.
Publicado: (2014)

Sensing the enemy within: how macrophages detect intracellular Gram-negative bacteria
por: Demon, Dieter, et al.
Publicado: (2014)

Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
por: Walle, Lieselotte Vande, et al.
Publicado: (2014)

Bacterial recognition pathways that lead to inflammasome activation
por: Storek, Kelly M, et al.
Publicado: (2015)

The inflammasome adaptor ASC regulates adaptive immune cell functions by controlling DOCK2-mediated Rac activation and actin polymerization
por: Ippagunta, Sirish K., et al.
Publicado: (2011)

The Inflammasomes
por: Lamkanfi, Mohamed, et al.
Publicado: (2009)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019)

Nonredundancy of IL-1α and IL-1β is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection
por: Eislmayr, Kevin, et al.
Publicado: (2022)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

Modulation of immune responses using adjuvants to facilitate therapeutic vaccination
por: Schijns, Virgil, et al.
Publicado: (2020)

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
por: Onyango, Isaac G.
Publicado: (2018)

Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017)

Dietary modulation of the microbiome affects autoinflammatory disease
por: Lukens, John R., et al.
Publicado: (2014)

Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
por: Kang, Seung Hyun, et al.
Publicado: (2021)

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
por: Dreismann, Anna K, et al.
Publicado: (2022)

Caspase-1 Engagement and TLR-Induced c-FLIP Expression Suppress ASC/Caspase-8-Dependent Apoptosis by Inflammasome Sensors NLRP1b and NLRC4
por: Van Opdenbosch, Nina, et al.
Publicado: (2017)

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
por: Vande Walle, Lieselotte, et al.
Publicado: (2019)

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
por: Walle, Lieselotte Vande, et al.
Publicado: (2019)

Mitophagy: a balance regulator of NLRP3 inflammasome activation
por: Kim, Min-Ji, et al.
Publicado: (2016)

The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target
por: Risitano, Antonio M., et al.
Publicado: (2022)

Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases
por: Hata, Masayuki, et al.
Publicado: (2017)

Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop
por: Ekdahl, Kristina N., et al.
Publicado: (2022)

Extremely low frequency electromagnetic fields stimulation modulates autoimmunity and immune responses: a possible immuno-modulatory therapeutic effect in neurodegenerative diseases
por: Guerriero, Fabio, et al.
Publicado: (2016)

The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
por: Mo, Jung-Soon
Publicado: (2017)

A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation
por: Voet, Sofie, et al.
Publicado: (2018)

Collagen for brain repair: therapeutic perspectives
por: Ucar, Buket, et al.
Publicado: (2018)

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention
por: Machhi, Jatin, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
por: Lenaerts, Anne, et al.
Publicado: (2015)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Effects and Mechanisms of Taurine as a Therapeutic Agent
por: Schaffer, Stephen, et al.
Publicado: (2018)

Therapeutic potential of adenosine kinase inhibition—Revisited
por: Jarvis, Michael F.
Publicado: (2019)

The promise of stem cell-based therapeutics in ophthalmology
por: Aharony, Israel, et al.
Publicado: (2017)

The vasculature: a therapeutic target in heart failure?
por: Luxán, Guillermo, et al.
Publicado: (2021)

The RISK pathway and beyond
por: Rossello, Xavier, et al.
Publicado: (2017)

HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
por: Lindl, Kathryn A., et al.
Publicado: (2010)

The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives
por: Chiba, Koji, et al.
Publicado: (2016)

Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
por: Bates, Jennifer, et al.
Publicado: (2014)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ik1gqar7rnctqab76318f387pg